$PGY
Pagaya Technologies Ltd Stock $pgy

$pgy Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000188308524000190 Filed on November 12, 2024

Income Statement

Concept	2024 Q3	2023 Q3
Revenue	$257.2M	$211.8M
YoY Change	21.48%	3.83%
Cost Of Revenue	$149.0M	$128.8M
YoY Change	15.66%	-0.25%
Gross Profit	$108.3M	$82.97M
YoY Change	30.5%	10.86%
Gross Profit Margin	42.09%	39.18%
Selling, General & Admin	$69.23M	$64.76M
YoY Change	6.9%	-35.47%
% of Gross Profit	63.94%	78.06%
Research & Development	$16.66M	$18.04M
YoY Change	-7.67%	-53.32%
% of Gross Profit	15.38%	21.74%
Depreciation & Amortization		$5.181M
YoY Change		27.08%
% of Gross Profit		6.24%
Operating Expenses	$85.89M	$82.80M
YoY Change	3.72%	-40.43%
Operating Profit	$22.38M	$162.0K
YoY Change	13717.28%	-100.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$108.1M	-$47.26M
YoY Change	128.82%	-1561.8%
Pretax Income	-$85.76M	-$47.10M
YoY Change	82.08%	-22.71%
Income Tax	-$11.52M	-$1.158M
% Of Pretax Income
Net Earnings	-$67.48M	-$21.75M
YoY Change	210.21%	-70.92%
Net Earnings / Revenue	-26.23%	-10.27%
Basic Earnings Per Share	-$0.93	-$0.36
Diluted Earnings Per Share	-$0.93	-$0.03
COMMON SHARES
Basic Shares Outstanding	72.73M shares	60.71M shares
Diluted Shares Outstanding	72.73M shares	60.71M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$252.6M
YoY Change		-22.97%
Cash & Equivalents	$147.1M	$252.6M
Short-Term Investments
Other Short-Term Assets		$53.63M
YoY Change		-5.36%
Inventory
Prepaid Expenses
Receivables		$67.46M
Other Receivables		$4.322M
Total Short-Term Assets	$298.5M	$378.0M
YoY Change	-21.04%	-13.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$39.36M	$95.27M
YoY Change	-58.69%	0.74%
Goodwill	$10.95M
YoY Change
Intangibles	$638.0K
YoY Change
Long-Term Investments	$25.78M	$26.55M
YoY Change	-2.91%	2.88%
Other Assets		$5.465M
YoY Change		-65.78%
Total Long-Term Assets	$1.072B	$842.2M
YoY Change	27.32%	37.97%
TOTAL ASSETS
Total Short-Term Assets	$298.5M	$378.0M
Total Long-Term Assets	$1.072B	$842.2M
Total Assets	$1.371B	$1.220B
YoY Change	12.34%	16.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.835M	$1.299M
YoY Change	349.19%	-47.68%
Accrued Expenses	$32.55M	$35.55M
YoY Change	-8.43%	-46.62%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$44.19M
YoY Change		391.96%
Total Short-Term Liabilities	$254.5M	$81.63M
YoY Change	211.72%	-8.27%
LONG-TERM LIABILITIES
Long-Term Debt		$327.4M
YoY Change		274.11%
Other Long-Term Liabilities		$64.54M
YoY Change		-18.67%
Total Long-Term Liabilities	$499.3M	$391.9M
YoY Change	27.41%	134.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$254.5M	$81.63M
Total Long-Term Liabilities	$499.3M	$391.9M
Total Liabilities	$753.8M	$610.0M
YoY Change	23.56%	26.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$706.1M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$462.3M	$610.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.371B	$1.220B
YoY Change	12.34%	16.26%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$67.48M	-$21.75M
YoY Change	210.21%	-70.92%
Depreciation, Depletion And Amortization		$5.181M
YoY Change		27.08%
Cash From Operating Activities		$16.14M
YoY Change		-142.86%
INVESTING ACTIVITIES
Capital Expenditures		$5.055M
YoY Change		-72.33%
Acquisitions
YoY Change
Other Investing Activities		-$120.2M
YoY Change		-30.76%
Cash From Investing Activities		-$125.2M
YoY Change		-34.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$4.901M
YoY Change		-98.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		63.40M
YoY Change		-83.82%
NET CHANGE
Cash From Operating Activities		16.14M
Cash From Investing Activities		-125.2M
Cash From Financing Activities		63.40M
Net Change In Cash		-45.68M
YoY Change		-128.11%
FREE CASH FLOW
Cash From Operating Activities		$16.14M
Capital Expenditures		$5.055M
Free Cash Flow		$11.08M
YoY Change		-119.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	30965000	usd
	pgy	Income Loss From Equity Method Investments Including Proprietary Investments IncomeLossFromEquityMethodInvestmentsIncludingProprietaryInvestments	-699000	usd
	pgy	Income Loss From Equity Method Investments Including Proprietary Investments IncomeLossFromEquityMethodInvestmentsIncludingProprietaryInvestments	656000	usd
CY2023Q3	us-gaap	Revenues Revenues	211757000	usd
	us-gaap	Revenues Revenues	752854000	usd
	us-gaap	Revenues Revenues	594007000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	148965000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	128792000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	439448000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16655000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18039000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11440000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.35
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72728667	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72728667	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60713648	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60713648	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-74231000	usd
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	51600000	usd
	dei	Document Type DocumentType	10-Q
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57970000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56833000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11339000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	35028000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	40197000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57790000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53425000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	185307000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	234850000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	211595000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	22384000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.91
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59617660	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-74231000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-45940000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19179000	usd
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	3942000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	26836000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-45940000	usd
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181047000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	284178000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41430
	dei	Entity Registrant Name EntityRegistrantName	Pagaya Technologies Ltd.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3083236
	dei	Entity Address Address Line1 EntityAddressAddressLine1	90 Park Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	20th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10016
	dei	City Area Code CityAreaCode	646
	dei	Local Phone Number LocalPhoneNumber	710-7714
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147099000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	186478000	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	17617000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	16874000	usd
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	98280000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	79526000	usd
CY2024Q3	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	11251000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	2490000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24214000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18034000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	298461000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	303402000	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	16331000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	19189000	usd
CY2024Q3	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	30783000	usd
CY2023Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	34181000	usd
CY2024Q3	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	912131000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	714303000	usd
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	25778000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	26383000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34087000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55729000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39359000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2550000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	1064000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	137000	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	us-gaap	Goodwill Goodwill	10945000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	10945000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	638000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001883085
CY2024Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0833
CY2024Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0833
CY2024Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0833
CY2024Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0833
CY2024Q3	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccountsAndOtherReceivablesNetCurrent
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccountsAndOtherReceivablesNetCurrent
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTax
CY2023Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTax
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTax
CY2024Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTax
CY2024Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0833
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41557000	usd
CY2024Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	1198000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1072314000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	904974000	usd
CY2024Q3	us-gaap	Assets Assets	1370775000	usd
CY2023Q4	us-gaap	Assets Assets	1208376000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5835000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1286000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32550000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28562000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5491000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6931000	usd
CY2024Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	12750000	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0	usd
CY2024Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	195457000	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	37685000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2370000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	461000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	254453000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	74925000	usd
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2884000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3242000	usd
CY2024Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15000000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	90000000	usd
CY2024Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	217424000	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	0	usd
CY2024Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	213268000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	234028000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27693000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43940000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	22839000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	22135000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	189000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	499297000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	393452000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	753750000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	468377000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6666666	shares
CY2024Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6666666	shares
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5000000	shares
CY2024Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5000000	shares
CY2024Q3	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	150000000	usd
CY2023Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	150000000	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1258862000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1101914000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-90432000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	444000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-706121000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-542637000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	462309000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	559721000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	80466000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	106028000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	542775000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	665749000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1370775000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1208376000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	249283000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	201447000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	728881000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	562386000	usd
CY2024Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	8735000	usd
CY2023Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10375000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	24672000	usd
CY2024Q3	pgy	Income Loss From Equity Method Investments Including Proprietary Investments IncomeLossFromEquityMethodInvestmentsIncludingProprietaryInvestments	-784000	usd
CY2023Q3	pgy	Income Loss From Equity Method Investments Including Proprietary Investments IncomeLossFromEquityMethodInvestmentsIncludingProprietaryInvestments	-65000	usd
CY2024Q3	us-gaap	Revenues Revenues	257234000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	374462000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	157567000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	717753000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	629059000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	162000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	35101000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-35052000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-108139000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47260000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-215682000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-131135000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-85755000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-47098000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-180581000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-166187000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11524000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1158000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7991000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10515000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-74231000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-45940000	usd
	us-gaap	Profit Loss ProfitLoss	-188572000	usd
	us-gaap	Profit Loss ProfitLoss	-176702000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6755000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-24188000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25088000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-62682000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-67476000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-21752000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-163484000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-114020000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69619813	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69619813	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59617660	shares
	us-gaap	Profit Loss ProfitLoss	-188572000	usd
	us-gaap	Profit Loss ProfitLoss	-176702000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5084000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-86273000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27911000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-93410000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-40856000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-274845000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-148791000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-6552000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-21126000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-20485000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-39469000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-86858000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19730000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-254360000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-109322000	usd
CY2024Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	615574000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1736000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	665000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13890000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6894000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2574000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-19179000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	542775000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	665749000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2495000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	665000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5312000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2815000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7892000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-86273000	usd
	us-gaap	Profit Loss ProfitLoss	-188572000	usd
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	542775000	usd
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	703123000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1108000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23177000	usd
CY2023Q3	pgy	Adjustments To Additional Paid In Capital Stock Issued Reversal Of Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedReversalOfIssuanceCosts	4401000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	5084000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	671852000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	765423000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2538000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	750000	usd
	pgy	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	5000000	shares
	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	74250000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	62868000	usd
	pgy	Adjustments To Additional Paid In Capital Stock Issued Reversal Of Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedReversalOfIssuanceCosts	4401000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	18134000	usd
	us-gaap	Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax	16460000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	19235000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	55749000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	11451000	usd
	us-gaap	Profit Loss ProfitLoss	-176702000	usd
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000000	shares
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74250000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	671852000	usd
	us-gaap	Profit Loss ProfitLoss	-188572000	usd
	us-gaap	Profit Loss ProfitLoss	-176702000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-699000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	655000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20475000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13161000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	45852000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	57312000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-358000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3763000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-155960000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-115644000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	3145000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1935000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1162000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2065000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4178000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	302000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-367000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	15332000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	7666000	usd
	pgy	Increase Decrease In Deferred Tax Liabilities Net IncreaseDecreaseInDeferredTaxLiabilitiesNet	-82000	usd
	pgy	Increase Decrease In Deferred Tax Liabilities Net IncreaseDecreaseInDeferredTaxLiabilitiesNet	-13000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8213000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1812000	usd
	pgy	Increase Decrease In Operating Right Of Use Asset IncreaseDecreaseInOperatingRightOfUseAsset	-1462000	usd
	pgy	Increase Decrease In Operating Right Of Use Asset IncreaseDecreaseInOperatingRightOfUseAsset	-6435000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4607000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-374000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4121000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-16682000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-441000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6433000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	4360000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	529000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34457000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9372000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	89905000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	134101000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	31000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	1608000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	538727000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	436242000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13761000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15555000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	125000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-462677000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316088000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	89956000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	244725000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	usd
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	74250000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	254895000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	314276000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2815000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	19235000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	59000000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	110000000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3160000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2538000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	11865000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3793000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	7892000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	39321000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	134000000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	25000000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	117883000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	182358000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	9563000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7974000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	650000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1198000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	387906000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276763000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1180000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4201000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41494000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52898000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	222541000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	337076000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181047000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	284178000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147099000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	252578000	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	17617000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	26280000	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	16331000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	5320000	usd
	us-gaap	Nature Of Operations NatureOfOperations	BUSINESS DESCRIPTION <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pagaya Technologies Ltd. and its consolidated subsidiaries (together “we” “our” “Pagaya” or the “Company”) is a technology company that deploys sophisticated data science and proprietary AI technology to drive better results for financial services and other service providers, their customers, and asset investors. Services providers integrated with Pagaya’s network, which are referred to as “Partners,” range from high-growth financial technology companies to incumbent banks and financial institutions, auto finance providers and residential real estate service providers. Partners have access to Pagaya’s network in order to assist with extending financial products to their customers, in turn helping those customers fulfill their financial needs and dreams. These assets originated by Partners with the assistance of Pagaya’s AI technology are eligible to be acquired by (i) funds managed or advised by Pagaya or one of its affiliates, (ii) securitization vehicles sponsored or administered by Pagaya or one of its affiliates and (iii) other similar vehicles (“Financing Vehicles”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pagaya Technologies Ltd. was founded in 2016 and is organized under the laws of the State of Israel. Pagaya has its primary offices in the United States and Israel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reverse Share Split</span></div>Share amounts have been retrospectively adjusted to reflect the 1-for-12 reverse share split effected on March 8, 2024.
	pgy	Revenue From Contracts With Customer Number Of Revenue Streams RevenueFromContractsWithCustomerNumberOfRevenueStreams	2	revenuestream
CY2024Q3	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	300000	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	2900000	usd
CY2023Q3	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	1800000	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	100000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	249283000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	201447000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	728881000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	562386000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3188000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12750000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	12750000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	12750000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	12750000	usd
CY2024Q3	pgy	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	191250000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	245438000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15264000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	230174000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	1256711000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13828000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	94223000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	252934000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	923382000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	13400000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	811874000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19313000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	13436000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	100958000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	716793000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	12500000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	18575000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4930000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	28418000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	674000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	46993000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	5604000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	75724000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3846000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	75724000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3846000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	11311000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	11251000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1245400000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	912131000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	1256711000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	923382000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2508000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2490000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	809366000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	714303000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	811874000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	716793000	usd
CY2024Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	23083000	usd
CY2023Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	42741000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	89905000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	134101000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	4810000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	37758000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	7109000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	38636000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	79171000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	37314000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	159085000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	115640000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	178130000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	21118000	usd
CY2024Q3	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Period Increase Decrease OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsPeriodIncreaseDecrease	58053000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	4810000	usd
CY2024Q3	pgy	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Recovery Net DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossRecoveryNet	443000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	252934000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	100958000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	112263000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	3246000	usd
	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Period Increase Decrease OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsPeriodIncreaseDecrease	43576000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	7109000	usd
	pgy	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Recovery Net DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossRecoveryNet	0	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	252934000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	77448000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	37314000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	37758000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	77004000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	115640000	usd
	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	38636000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	77004000	usd
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	25778000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	26383000	usd
CY2024Q3	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	828444000	usd
CY2023Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	591030000	usd
CY2024Q3	us-gaap	Security Deposit SecurityDeposit	3300000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	4800000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2900000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	3275000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	8748000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	10061000	usd
CY2024Q3	pgy	Variable Lease Cost Net Of Refunds VariableLeaseCostNetOfRefunds	87000	usd
CY2023Q3	pgy	Variable Lease Cost Net Of Refunds VariableLeaseCostNetOfRefunds	72000	usd
	pgy	Variable Lease Cost Net Of Refunds VariableLeaseCostNetOfRefunds	260000	usd
	pgy	Variable Lease Cost Net Of Refunds VariableLeaseCostNetOfRefunds	203000	usd
CY2024Q3	us-gaap	Sublease Income SubleaseIncome	999000	usd
CY2023Q3	us-gaap	Sublease Income SubleaseIncome	1035000	usd
	us-gaap	Sublease Income SubleaseIncome	3007000	usd
	us-gaap	Sublease Income SubleaseIncome	3154000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M24D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.087
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061
CY2024Q3	pgy	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Derecognized Asset RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDerecognizedAsset	-19961000	usd
CY2023Q3	pgy	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Derecognized Asset RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDerecognizedAsset	0	usd
	pgy	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Derecognized Asset RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDerecognizedAsset	-20179000	usd
	pgy	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Derecognized Asset RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDerecognizedAsset	290000	usd
CY2024Q3	pgy	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Derecognized Asset RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDerecognizedAsset	-20000000	usd
	pgy	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Derecognized Asset RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDerecognizedAsset	-20200000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2355000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7355000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7000000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5883000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5093000	usd
CY2024Q3	pgy	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	15104000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42790000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9606000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	33184000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	4600000	usd
CY2024Q3	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	4900000	usd
CY2024Q3	us-gaap	Other Commitment OtherCommitment	30100000	usd
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2884000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3242000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1671000	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1213000	usd
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2884000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3242000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-358000	usd
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2884000	usd
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3835000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1328000	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5163000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1400000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3763000	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5163000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	911425000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	590455000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	716793000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	480437000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	130268000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	162903000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	538727000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	436242000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	23083000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	42741000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	89905000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	134101000	usd
CY2024Q3	pgy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset In Kind Distributions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInKindDistributions	0	usd
	pgy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset In Kind Distributions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInKindDistributions	12730000	usd
	pgy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset In Kind Distributions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInKindDistributions	0	usd
	pgy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset In Kind Distributions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInKindDistributions	12730000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-19179000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	5083000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-86273000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	11450000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	76049000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	37316000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	155960000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	115644000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	923382000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	665654000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	923382000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	665654000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	181047000	usd
CY2024Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	129063000	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	310110000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	222541000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	113707000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	336248000	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	839999998	shares
CY2024Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6666666	shares
CY2024Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	43789368	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	39638471	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4250988	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.2
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	43940000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4450	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	508941	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.1
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	257259	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	21.2
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3489238	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.4
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20949000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3148937	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	5.3
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	22276000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3200000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7600000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	58800000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	63600000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.955
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.036
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	21400000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12333000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20737000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45852000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57312000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-85755000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-47098000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-180581000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-166187000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11524000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1158000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7991000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10515000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.134
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.025
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.044
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.063
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33304195	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35040350	shares
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001883085-24-000190-index-headers.html	Edgar Link	pending
0001883085-24-000190-index.html	Edgar Link	pending
0001883085-24-000190.txt	Edgar Link	pending
0001883085-24-000190-xbrl.zip	Edgar Link	pending
exhibit101secondamendmen.htm	Edgar Link	pending
exhibit101secondamendmen001.jpg	Edgar Link	pending
exhibit101secondamendmen002.jpg	Edgar Link	pending
exhibit101secondamendmen003.jpg	Edgar Link	pending
exhibit101secondamendmen004.jpg	Edgar Link	pending
exhibit101secondamendmen005.jpg	Edgar Link	pending
exhibit101secondamendmen006.jpg	Edgar Link	pending
exhibit101secondamendmen007.jpg	Edgar Link	pending
exhibit101secondamendmen008.jpg	Edgar Link	pending
exhibit101secondamendmen009.jpg	Edgar Link	pending
exhibit101secondamendmen010.jpg	Edgar Link	pending
exhibit101secondamendmen011.jpg	Edgar Link	pending
exhibit101secondamendmen012.jpg	Edgar Link	pending
exhibit101secondamendmen013.jpg	Edgar Link	pending
exhibit101secondamendmen014.jpg	Edgar Link	pending
exhibit101secondamendmen015.jpg	Edgar Link	pending
exhibit101secondamendmen016.jpg	Edgar Link	pending
exhibit101secondamendmen017.jpg	Edgar Link	pending
exhibit101secondamendmen018.jpg	Edgar Link	pending
exhibit101secondamendmen019.jpg	Edgar Link	pending
exhibit101secondamendmen020.jpg	Edgar Link	pending
exhibit101secondamendmen021.jpg	Edgar Link	pending
exhibit101secondamendmen022.jpg	Edgar Link	pending
exhibit101secondamendmen023.jpg	Edgar Link	pending
exhibit101secondamendmen024.jpg	Edgar Link	pending
exhibit101secondamendmen025.jpg	Edgar Link	pending
exhibit101secondamendmen026.jpg	Edgar Link	pending
exhibit101secondamendmen027.jpg	Edgar Link	pending
exhibit101secondamendmen028.jpg	Edgar Link	pending
exhibit101secondamendmen029.jpg	Edgar Link	pending
exhibit101secondamendmen030.jpg	Edgar Link	pending
exhibit101secondamendmen031.jpg	Edgar Link	pending
exhibit101secondamendmen032.jpg	Edgar Link	pending
exhibit101secondamendmen033.jpg	Edgar Link	pending
exhibit101secondamendmen034.jpg	Edgar Link	pending
exhibit101secondamendmen035.jpg	Edgar Link	pending
exhibit101secondamendmen036.jpg	Edgar Link	pending
exhibit101secondamendmen037.jpg	Edgar Link	pending
exhibit101secondamendmen038.jpg	Edgar Link	pending
exhibit101secondamendmen039.jpg	Edgar Link	pending
exhibit101secondamendmen040.jpg	Edgar Link	pending
exhibit101secondamendmen041.jpg	Edgar Link	pending
exhibit101secondamendmen042.jpg	Edgar Link	pending
exhibit101secondamendmen043.jpg	Edgar Link	pending
exhibit101secondamendmen044.jpg	Edgar Link	pending
exhibit101secondamendmen045.jpg	Edgar Link	pending
exhibit101secondamendmen046.jpg	Edgar Link	pending
exhibit101secondamendmen047.jpg	Edgar Link	pending
exhibit101secondamendmen048.jpg	Edgar Link	pending
exhibit101secondamendmen049.jpg	Edgar Link	pending
exhibit101secondamendmen050.jpg	Edgar Link	pending
exhibit101secondamendmen051.jpg	Edgar Link	pending
exhibit101secondamendmen052.jpg	Edgar Link	pending
exhibit101secondamendmen053.jpg	Edgar Link	pending
exhibit101secondamendmen054.jpg	Edgar Link	pending
exhibit101secondamendmen055.jpg	Edgar Link	pending
exhibit101secondamendmen056.jpg	Edgar Link	pending
exhibit101secondamendmen057.jpg	Edgar Link	pending
exhibit101secondamendmen058.jpg	Edgar Link	pending
exhibit101secondamendmen059.jpg	Edgar Link	pending
exhibit101secondamendmen060.jpg	Edgar Link	pending
exhibit101secondamendmen061.jpg	Edgar Link	pending
exhibit101secondamendmen062.jpg	Edgar Link	pending
exhibit101secondamendmen063.jpg	Edgar Link	pending
exhibit101secondamendmen064.jpg	Edgar Link	pending
exhibit101secondamendmen065.jpg	Edgar Link	pending
exhibit101secondamendmen066.jpg	Edgar Link	pending
exhibit101secondamendmen067.jpg	Edgar Link	pending
exhibit101secondamendmen068.jpg	Edgar Link	pending
exhibit101secondamendmen069.jpg	Edgar Link	pending
exhibit101secondamendmen070.jpg	Edgar Link	pending
exhibit101secondamendmen071.jpg	Edgar Link	pending
exhibit101secondamendmen072.jpg	Edgar Link	pending
exhibit101secondamendmen073.jpg	Edgar Link	pending
exhibit101secondamendmen074.jpg	Edgar Link	pending
exhibit101secondamendmen075.jpg	Edgar Link	pending
exhibit101secondamendmen076.jpg	Edgar Link	pending
exhibit101secondamendmen077.jpg	Edgar Link	pending
exhibit101secondamendmen078.jpg	Edgar Link	pending
exhibit101secondamendmen079.jpg	Edgar Link	pending
exhibit101secondamendmen080.jpg	Edgar Link	pending
exhibit101secondamendmen081.jpg	Edgar Link	pending
exhibit101secondamendmen082.jpg	Edgar Link	pending
exhibit101secondamendmen083.jpg	Edgar Link	pending
exhibit101secondamendmen084.jpg	Edgar Link	pending
exhibit101secondamendmen085.jpg	Edgar Link	pending
exhibit101secondamendmen086.jpg	Edgar Link	pending
exhibit101secondamendmen087.jpg	Edgar Link	pending
exhibit101secondamendmen088.jpg	Edgar Link	pending
exhibit101secondamendmen089.jpg	Edgar Link	pending
exhibit101secondamendmen090.jpg	Edgar Link	pending
exhibit101secondamendmen091.jpg	Edgar Link	pending
exhibit101secondamendmen092.jpg	Edgar Link	pending
exhibit101secondamendmen093.jpg	Edgar Link	pending
exhibit101secondamendmen094.jpg	Edgar Link	pending
exhibit101secondamendmen095.jpg	Edgar Link	pending
exhibit101secondamendmen096.jpg	Edgar Link	pending
exhibit101secondamendmen097.jpg	Edgar Link	pending
exhibit101secondamendmen098.jpg	Edgar Link	pending
exhibit101secondamendmen099.jpg	Edgar Link	pending
exhibit101secondamendmen100.jpg	Edgar Link	pending
exhibit101secondamendmen101.jpg	Edgar Link	pending
exhibit101secondamendmen102.jpg	Edgar Link	pending
exhibit101secondamendmen103.jpg	Edgar Link	pending
exhibit101secondamendmen104.jpg	Edgar Link	pending
exhibit101secondamendmen105.jpg	Edgar Link	pending
exhibit101secondamendmen106.jpg	Edgar Link	pending
exhibit101secondamendmen107.jpg	Edgar Link	pending
exhibit101secondamendmen108.jpg	Edgar Link	pending
exhibit101secondamendmen109.jpg	Edgar Link	pending
exhibit101secondamendmen110.jpg	Edgar Link	pending
exhibit101secondamendmen111.jpg	Edgar Link	pending
exhibit101secondamendmen112.jpg	Edgar Link	pending
exhibit101secondamendmen113.jpg	Edgar Link	pending
exhibit101secondamendmen114.jpg	Edgar Link	pending
exhibit101secondamendmen115.jpg	Edgar Link	pending
exhibit101secondamendmen116.jpg	Edgar Link	pending
exhibit101secondamendmen117.jpg	Edgar Link	pending
exhibit101secondamendmen118.jpg	Edgar Link	pending
exhibit101secondamendmen119.jpg	Edgar Link	pending
exhibit101secondamendmen120.jpg	Edgar Link	pending
exhibit101secondamendmen121.jpg	Edgar Link	pending
exhibit101secondamendmen122.jpg	Edgar Link	pending
exhibit101secondamendmen123.jpg	Edgar Link	pending
exhibit101secondamendmen124.jpg	Edgar Link	pending
exhibit101secondamendmen125.jpg	Edgar Link	pending
exhibit101secondamendmen126.jpg	Edgar Link	pending
exhibit101secondamendmen127.jpg	Edgar Link	pending
exhibit101secondamendmen128.jpg	Edgar Link	pending
exhibit101secondamendmen129.jpg	Edgar Link	pending
exhibit101secondamendmen130.jpg	Edgar Link	pending
exhibit101secondamendmen131.jpg	Edgar Link	pending
exhibit101secondamendmen132.jpg	Edgar Link	pending
exhibit101secondamendmen133.jpg	Edgar Link	pending
exhibit101secondamendmen134.jpg	Edgar Link	pending
exhibit101secondamendmen135.jpg	Edgar Link	pending
exhibit101secondamendmen136.jpg	Edgar Link	pending
exhibit101secondamendmen137.jpg	Edgar Link	pending
exhibit101secondamendmen138.jpg	Edgar Link	pending
exhibit101secondamendmen139.jpg	Edgar Link	pending
exhibit101secondamendmen140.jpg	Edgar Link	pending
exhibit101secondamendmen141.jpg	Edgar Link	pending
exhibit101secondamendmen142.jpg	Edgar Link	pending
exhibit101secondamendmen143.jpg	Edgar Link	pending
exhibit101secondamendmen144.jpg	Edgar Link	pending
exhibit101secondamendmen145.jpg	Edgar Link	pending
exhibit101secondamendmen146.jpg	Edgar Link	pending
exhibit101secondamendmen147.jpg	Edgar Link	pending
exhibit101secondamendmen148.jpg	Edgar Link	pending
exhibit101secondamendmen149.jpg	Edgar Link	pending
exhibit101secondamendmen150.jpg	Edgar Link	pending
exhibit101secondamendmen151.jpg	Edgar Link	pending
exhibit101secondamendmen152.jpg	Edgar Link	pending
exhibit101secondamendmen153.jpg	Edgar Link	pending
exhibit101secondamendmen154.jpg	Edgar Link	pending
exhibit101secondamendmen155.jpg	Edgar Link	pending
exhibit101secondamendmen156.jpg	Edgar Link	pending
exhibit101secondamendmen157.jpg	Edgar Link	pending
exhibit101secondamendmen158.jpg	Edgar Link	pending
exhibit101secondamendmen159.jpg	Edgar Link	pending
exhibit101secondamendmen160.jpg	Edgar Link	pending
exhibit101secondamendmen161.jpg	Edgar Link	pending
exhibit101secondamendmen162.jpg	Edgar Link	pending
exhibit101secondamendmen163.jpg	Edgar Link	pending
exhibit101secondamendmen164.jpg	Edgar Link	pending
exhibit101secondamendmen165.jpg	Edgar Link	pending
exhibit101secondamendmen166.jpg	Edgar Link	pending
exhibit101secondamendmen167.jpg	Edgar Link	pending
exhibit101secondamendmen168.jpg	Edgar Link	pending
exhibit101secondamendmen169.jpg	Edgar Link	pending
exhibit101secondamendmen170.jpg	Edgar Link	pending
exhibit101secondamendmen171.jpg	Edgar Link	pending
exhibit101secondamendmen172.jpg	Edgar Link	pending
exhibit101secondamendmen173.jpg	Edgar Link	pending
exhibit101secondamendmen174.jpg	Edgar Link	pending
exhibit101secondamendmen175.jpg	Edgar Link	pending
exhibit101secondamendmen176.jpg	Edgar Link	pending
exhibit101secondamendmen177.jpg	Edgar Link	pending
exhibit101secondamendmen178.jpg	Edgar Link	pending
exhibit101secondamendmen179.jpg	Edgar Link	pending
exhibit101secondamendmen180.jpg	Edgar Link	pending
exhibit101secondamendmen181.jpg	Edgar Link	pending
exhibit101secondamendmen182.jpg	Edgar Link	pending
exhibit101secondamendmen183.jpg	Edgar Link	pending
exhibit101secondamendmen184.jpg	Edgar Link	pending
exhibit101secondamendmen185.jpg	Edgar Link	pending
exhibit101secondamendmen186.jpg	Edgar Link	pending
exhibit101secondamendmen187.jpg	Edgar Link	pending
exhibit101secondamendmen188.jpg	Edgar Link	pending
exhibit101secondamendmen189.jpg	Edgar Link	pending
exhibit101secondamendmen190.jpg	Edgar Link	pending
exhibit101secondamendmen191.jpg	Edgar Link	pending
exhibit101secondamendmen192.jpg	Edgar Link	pending
exhibit101secondamendmen193.jpg	Edgar Link	pending
exhibit101secondamendmen194.jpg	Edgar Link	pending
exhibit101secondamendmen195.jpg	Edgar Link	pending
exhibit101secondamendmen196.jpg	Edgar Link	pending
exhibit101secondamendmen197.jpg	Edgar Link	pending
exhibit101secondamendmen198.jpg	Edgar Link	pending
exhibit101secondamendmen199.jpg	Edgar Link	pending
exhibit101secondamendmen200.jpg	Edgar Link	pending
exhibit101secondamendmen201.jpg	Edgar Link	pending
exhibit101secondamendmen202.jpg	Edgar Link	pending
exhibit101secondamendmen203.jpg	Edgar Link	pending
exhibit101secondamendmen204.jpg	Edgar Link	pending
exhibit101secondamendmen205.jpg	Edgar Link	pending
exhibit101secondamendmen206.jpg	Edgar Link	pending
exhibit101secondamendmen207.jpg	Edgar Link	pending
exhibit311ceocertification.htm	Edgar Link	pending
exhibit312cfocertification.htm	Edgar Link	pending
exhibit321ceocertification.htm	Edgar Link	pending
exhibit322cfocertification.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gkrubinereaedgar.htm	Edgar Link	pending
gkrubinereaedgar001.jpg	Edgar Link	pending
gkrubinereaedgar002.jpg	Edgar Link	pending
gkrubinereaedgar003.jpg	Edgar Link	pending
gkrubinereaedgar004.jpg	Edgar Link	pending
gkrubinereaedgar005.jpg	Edgar Link	pending
gkrubinereaedgar006.jpg	Edgar Link	pending
gkrubinereaedgar007.jpg	Edgar Link	pending
gkrubinereaedgar008.jpg	Edgar Link	pending
gkrubinereaedgar009.jpg	Edgar Link	pending
gkrubinereaedgar010.jpg	Edgar Link	pending
gkrubinereaedgar011.jpg	Edgar Link	pending
gkrubinereaedgar012.jpg	Edgar Link	pending
gkrubinereaedgar013.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pgy-20240930.htm	Edgar Link	pending
pgy-20240930.xsd	Edgar Link	pending
pgy-20240930_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
pgy-20240930_def.xml	Edgar Link	unprocessable
pgy-20240930_lab.xml	Edgar Link	unprocessable
pgy-20240930_pre.xml	Edgar Link	unprocessable
pgy-20240930_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
troseneaedgar.htm	Edgar Link	pending
troseneaedgar001.jpg	Edgar Link	pending
troseneaedgar002.jpg	Edgar Link	pending
troseneaedgar003.jpg	Edgar Link	pending
troseneaedgar004.jpg	Edgar Link	pending
troseneaedgar005.jpg	Edgar Link	pending
troseneaedgar006.jpg	Edgar Link	pending
troseneaedgar007.jpg	Edgar Link	pending
troseneaedgar008.jpg	Edgar Link	pending
troseneaedgar009.jpg	Edgar Link	pending
troseneaedgar010.jpg	Edgar Link	pending
troseneaedgar011.jpg	Edgar Link	pending
troseneaedgar012.jpg	Edgar Link	pending
troseneaedgar013.jpg	Edgar Link	pending
yyulzarieaedgar.htm	Edgar Link	pending
yyulzarieaedgar001.jpg	Edgar Link	pending
yyulzarieaedgar002.jpg	Edgar Link	pending
yyulzarieaedgar003.jpg	Edgar Link	pending
yyulzarieaedgar004.jpg	Edgar Link	pending
yyulzarieaedgar005.jpg	Edgar Link	pending
yyulzarieaedgar006.jpg	Edgar Link	pending
yyulzarieaedgar007.jpg	Edgar Link	pending
yyulzarieaedgar008.jpg	Edgar Link	pending
yyulzarieaedgar009.jpg	Edgar Link	pending
yyulzarieaedgar010.jpg	Edgar Link	pending
yyulzarieaedgar011.jpg	Edgar Link	pending
yyulzarieaedgar012.jpg	Edgar Link	pending
yyulzarieaedgar013.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pgy-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PGY
Pagaya Technologies Ltd Stock $pgy

2024 Q3 Form 10-Q Financial Statement

#000188308524000190 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGY Pagaya Technologies Ltd Stock $pgy

2024 Q3 Form 10-Q Financial Statement

#000188308524000190 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGY
Pagaya Technologies Ltd Stock $pgy